Department of Health and Human Services September 29, 2021 – Federal Register Recent Federal Regulation Documents
Results 1 - 16 of 16
Submission for OMB Review; The Study of Disability Services Coordinators and Inclusion in Head Start (New Collection)
This is a primary data collection request for the Study of Disability Services Coordinators and Inclusion in Head Start (New Collection). The study aims to provide a nationally representative picture of the Early Head Start (EHS) and Head Start (HS) Disability Services Coordinator (DSC) workforce, as well as services provided to children with disabilities and their families within these programs and how EHS/HS collaborates with services in the community, including health providers, Local Education Agencies, and Part C. This is the first study of the HS/EHS DSC workforce and will contain three Phases of data collection using surveys and qualitative interviews.
Submission for OMB Review; Child and Family Services Reviews (OMB #0970-0214)
The Administration for Children and Families (ACF) is requesting reinstatement of the activities associated with the Child and Family Services Reviews (CFSR) collection (OMB #0970-0214). Revisions have been made to the forms to clarify instructions and incorporate new guidance. The activities associated with the Title IV-E Foster Care Eligibility Reviews and Anti-Discrimination Enforcement Corrective Action Plans were removed from this collection.
Electronic Submission Template for Medical Device 510(k) Submissions; Draft Guidance for Industry and Food and Drug Administration Staff; Availability
The Food and Drug Administration (FDA or Agency) is announcing the availability of the draft guidance entitled ``Electronic Submission Template for Medical Device 510(k) Submissions.'' FDA is issuing this draft guidance to introduce submitters of premarket notification (510(k)) submissions to the Center for Devices and Radiological Health and Center for Biologics Evaluation and Research to the current resources and associated content developed to support 510(k) electronic submissions to FDA. This draft guidance, when finalized, is intended to represent one of several steps in meeting FDA's commitment to the development of electronic submission templates to serve as guided submission preparation tools for industry to improve submission consistency and enhance efficiency in the review process. This draft guidance is not final nor is it in effect at this time.
Nontuberculous Mycobacterial Pulmonary Disease Caused by Mycobacterium avium Complex: Developing Drugs for Treatment; Draft Guidance for Industry; Availability
The Food and Drug Administration (FDA or Agency) is announcing the availability of a draft guidance for industry entitled ``Nontuberculous Mycobacterial Pulmonary Disease Caused by Mycobacterium avium Complex: Developing Drugs for Treatment.'' The purpose of this draft guidance is to assist sponsors in the clinical development of drugs for the treatment of nontuberculous mycobacterial pulmonary disease (NTM-PD) caused by Mycobacterium avium complex (MAC).
This site is protected by reCAPTCHA and the Google
Privacy Policy and
Terms of Service apply.